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the lateral neocortex is critical 
for contextual fear memory 
reconsolidation
Verónica de la fuente  1,2, Candela Medina1,2, Germán falasco3, Leandro Urrutia3, 
Alexxai V. Kravitz4, Francisco J. Urbano1,2, Silvia Vázquez3, María Eugenia pedreira1,2 & 
Arturo Romano1,2
Memories are a product of the concerted activity of many brain areas. Deregulation of consolidation 
and reprocessing of mnemonic traces that encode fearful experiences might result in fear-related 
psychopathologies. Here, we assessed how pre-established memories change with experience, 
particularly the labilization/reconsolidation of memory, using the whole-brain analysis technique of 
positron emission tomography in male mice. We found differences in glucose consumption in the lateral 
neocortex, hippocampus and amygdala in mice that underwent labilization/reconsolidation processes 
compared to animals that did not reactivate a fear memory. We used chemogenetics to obtain insight 
into the role of cortical areas in these phases of memory and found that the lateral neocortex is 
necessary for fear memory reconsolidation. Inhibition of lateral neocortex during reconsolidation 
altered glucose consumption levels in the amygdala. Using an optogenetic/neuronal recording-based 
strategy we observed that the lateral neocortex is functionally connected with the amygdala, which, 
along with retrograde labeling using fluorophore-conjugated cholera toxin subunit B, support a 
monosynaptic connection between these areas and poses this connection as a hot-spot in the circuits 
involved in reactivation of fear memories.
Consolidation is the process by which new information is encoded in neural circuits. However, most consolidated 
memories do not remain immutable indefinitely1–3; instead, they may change over time and with experience. 
Each time a reminder of the learning event is presented to an animal that has learned something new, the original 
memory can take distinct courses based on the specific characteristics of the reminder4,5. Specifically, a short 
re-exposure to the training context in rodents subjected to a contextual fear conditioning protocol triggers the 
expression of fear memory, and the trace may become labile and susceptible to disruption. The process of recon-
solidation is needed for trace re-stabilization6–8, enabling changes in its strength9–11 and/or content12,13. In recent 
decades, labilization, reconsolidation and expression have been extensively studied using behavioral, cellular and 
molecular approaches in rodent models14,15. However, no in vivo whole-brain studies have been performed to 
elucidate the neural circuits and brain areas that subserve memory dynamics during these processes in small 
animals, despite its relevance in improving our understanding of fear-related dysfunctions in humans, such as 
phobias and post-traumatic stress disorders16–18.
Functional imaging techniques such as functional magnetic resonance imaging (fMRI) and positron emission 
tomography (PET) are very powerful tools to investigate brain areas involved in different tasks, primarily because 
of their minimal invasiveness19, and are widely applied in humans and non-human primates20,21. However, the use 
of these tools is uncommon in small animals. One previous study used small-animal PET to better understand 
fear memories22, but no distinctions were made regarding memory labilization, reconsolidation and expression.
In the present work, we studied the mouse brain from a functional perspective using small-animal PET and 
the radioactive tracer [18F]-FDG for the measurement of glucose uptake to identify brain areas involved in the 
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labilization/reconsolidation of fear memory using a contextual fear-conditioning paradigm in mice. We found 
differences in glucose consumption in different regions including the temporal association cortex (TeA, also 
known as TEa), auditory areas (AUD), the perirhinal cortex (PER, also referred to as PRh or PERI), somatosen-
sory cortex, hippocampus and amygdala in animals that underwent labilization/reconsolidation processes com-
pared to animals that did not express the fear memory. The differences in glucose consumption revealed a marked 
temporal course of hyper- or hypo-consumption. Animals that only expressed but did not labilize/reconsolidate 
the memory trace exhibited significant differences from mice that both expressed the memory trace and under-
went labilization and reconsolidation.
As many studies have addressed the hippocampal and amygdalar role in cognitive processes, we focused on 
the remaining areas TEa, AUD and PER. From now on, we use the all-encompassing term “lateral neocortex” to 
refer to these areas. We performed directed neuronal inhibition using designer receptors exclusively activated by 
designer drugs (DREADDs)23,24 and found that this brain region is necessary for reconsolidation. Using retrograde 
labeling and an optogenetic/electrode array-based strategy we demonstrate that the lateral neocortex projects to 
the amygdala, which is a key structure for the processing of emotional information25.
Results
Distinguishing between reminders that do or do not induce labilization/reconsolidation. 
Different reminders of a learning event may elicit different neural processes, and the behavioral output may take 
different courses depending on the characteristics of the reminder4. As the aim of this work was to study brain 
areas involved in memory labilization/reconsolidation using small-animal PET methodology and because when 
an animal expresses a memory, labilization/reconsolidation might also be elicited26,27, our first goal was to find 
protocols that would enable us to distinguish these latter memory processes from memory expression itself. 
Suzuki and co-workers used a fear-conditioning paradigm in rats and reported that a brief re-exposure (i.e., 
3 min) to the training context one day after training elicited labilization/reconsolidation processes, whereas a 
shorter re-exposure of 1 min did not elicit these processes5,28,29. In line with these results, we trained ventricle-can-
nulated mice and separated the animals into 6 groups after 24 h. Two groups were re-exposed to the training 
context for 5 min, and half of these mice were injected with the protein synthesis inhibitor anisomycin (Ani; 
R5-Ani), which is a broadly used drug to induce memory impairment30–33. The other half of the mice received 
a vehicle solution (Veh; R5-Veh). Two other groups were re-exposed to the training context for only 1 min and 
subsequently injected with Ani or Veh (R1-Ani and R1-Veh, respectively). The last two groups were injected 
with Ani or Veh but not re-exposed (NR-Ani and NR-Veh, respectively). Memory was assessed 48 h after train-
ing (Fig. 1A). No differences in levels of freezing were observed in the first min of re-exposure in Ani vs. Veh 
injected mice (Fig. 1B; GLM: re-exposure effect: F(1,54) = 4.92, P = 0.031; drug effect: F(1,54) = 0.23, P = 0.63; inter-
action: F(1,54) = 0.72, P = 0.40; contrasts (Sidak): R5-Ani vs. R5-Veh: F(1,54) = 0.07, P = 0.96; R1-Ani vs. R1-Veh: 
F(1,54) = 0.91, P = 0.57). However, only the R5-Ani group exhibited a long-term memory deficit on day 3, which 
demonstrated that a re-exposure of 5 min, but not 1 min, was sufficient to induce memory labilization and recon-
solidation (Fig. 1C; GLM: re-exposure effect: F(2,78) = 3.47, P = 0.036; drug effect: F(1,78) = 2.94, P = 0.09; interac-
tion: F(2,78) = 1.25, P = 0.29; contrasts (Sidak): R5-Ani vs. R5-Veh: F(1,78) = 5.79, P = 0.037; NR-Ani vs. R5-Ani: 
F(1,78) = 7.32, P = 0.017).
Memory reconsolidation and positron emission tomography. Having characterized the experi-
mental conditions under which memory can be expressed or both expressed and labilized/reconsolidated, we 
performed an experiment similar to that illustrated in Fig. 1A but with the aim of analyzing local brain glucose 
consumption. We trained mice and the next day separated them into three groups (Fig. 1D; R5, R1 and NR). In 
the case of re-exposed animals, we administered [18F]-FDG intraperitoneally (IP) 10 min before the onset of 
a re-exposure session of either 5 or 1 min (R5 and R1, respectively). Five minutes after the mice were removed 
from the training context, we anesthetized them and PET images were acquired. We administered [18F]-FDG to 
non-re-exposed animals 24 h post-training and anesthetized them 20 min later. We chose the time of [18F]-FDG 
injection so that the behavioral moment of interest occurred in concordance with maximum radiotracer availa-
bility in brain plasma following IP injection34. Figure 1E shows that the freezing response of re-exposed groups 
was similar in the first min of re-exposure (GLM, F(1,21) = 0.01, P = 0.91). Figure 1F shows the PET results (pres-
ence of color indicates significant differences with P values less than 0.01, analyzed using pair-wise compari-
sons; complete results in Supplementary Fig. 1). Among the various brain areas showing statistical differences, 
the lateral neocortex clearly showed higher glucose consumption in the R5 group than in the NR group, and 
this differential signal was stronger in the right side of the brain. Some hyper-consumption was observed in 
R1 compared to NR, but in the lateral neocortex, R5 consumed more glucose than R1. Strikingly, R5 exhib-
ited a unilateral hypo-consumption in the amygdala compared to the NR group. Next, we evaluated whether 
the hyper-consumption observed in the lateral neocortex of the R5 group compared to NR group remained as 
hyper-consumption compared to naïve animals (Na). We performed another PET experiment to compare the 
glucose consumption of the Na and NR animals 24 h after TR. Pair-wise comparisons between these groups 
revealed significant differences in glucose consumption, but not in the lateral neocortex (Fig. 1F; Supplementary 
Fig. 1).
We administered [18F]-FDG at different time-points, taking the offset of re-exposure session as time zero, 
to identify the temporal course of local brain glucose consumption after exposure to specific contextual stim-
uli that elicit labilization/reconsolidation (Fig. 2A). Animals were re-exposed to the training context for 5 min 
24 h after the training session. We administered [18F]-FDG immediately prior to the re-exposure session to one 
group of animals (R5-pre) and 35 min after removal from the conditioning chamber to another group of ani-
mals (R5-35 min). A third group of animals was non-re-exposed (NR), injected with [18F]-FDG 24 h after the 
training and used for comparisons. Both re-exposed groups froze at similar levels during the re-exposure session 
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(Fig. 2B; GLM, F(1,22) = 0.02, P = 0.89). Pair-wise comparisons against the NR group indicated that the R5-pre 
mice exhibited a widely dispersed hypo-consumption in the brain, including the hippocampal areas (Fig. 2C, left; 
Supplementary Fig. 2). The R5-35 min mice exhibited a bilateral hyper-consumption in the amygdala (Fig. 2C, 
middle; Supplementary Fig. 2). Naïve mice did not exhibit differences in the aforementioned brain areas com-
pared to the NR mice (Fig. 2C, right; Supplementary Fig. 1).
We also investigated glucose consumption in 1-min re-exposed mice injected with [18F]-FDG 35 min after 
removal from the conditioning chamber (R1-35 min) to assess whether amygdalar hyper-consumption was 
related to the expression of memory itself or the labilization/reconsolidation processes. Pair-wise comparisons 
against NR animals revealed significant differences but not in the brain areas noted above (Supplementary Fig. 3).
Figure 1. Differential glucose consumption in animals that express and labilizate/reconsolidate memory vs. 
animals that only express memory. (A) Contextual fear conditioning design. Trained mice were separated into 
three behavioral groups: non- re-exposed animals (NR), 1 min re-exposed animals (R1) and 5 min re-exposed 
animals (R5), and then further divided each behavioral group into two groups, according to the injection (Ani: 
Anisomycin or Veh: vehicle). We tested all mice for contextual memory on day 3. n = 13–15. TR: training; Re-
exp: context re-exposure. Experimental procedures in day 2 are shown in grey. (B,C) Percentage of freezing on 
re-exposure and testing day, respectively. Data are shown as mean ± SEM. *P < 0.05. Inset shows ICV injection. 
(D) Experimental protocol, similar as in (A) but designed to measure glucose consumption. We injected mice 
[18F]-FDG IP 10 min pre re-exposure, and after re-exposure we anesthetized them with isoflurane and analyzed 
with PET (for simplicity both anaesthesia and acquisition of images with PET are altogether indicated as “PET 
scan”). Non-re-exposed mice were injected with [18F]-FDG 24 h post training. n = 11–12. (E) Percentage of 
freezing on re-exposure day. Data are shown as mean ± SEM. (F) Small-animal PET images corresponding to 
different coronal sections. The distance of each coronal section (in mm) relative to bregma is indicated in the 
upper scheme of the mouse brain (negative values for sections posterior to bregma). Data were analyzed using 
SPM ANOVA design and normalized through ANCOVA regressors. Comparisons yielding P values < 0.01 
are shown using a t statistic color scale, which corresponds to the level of significance at the voxel level 
(detailed color scales in Supplementary Fig. 1). Images are displayed with the left side corresponding to the left 
hemisphere, according to neurological conventions.
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One caveat of studying memory in animals that are treated with anesthesia is that, depending on the behav-
ioral experiment, it might affect the memory trace differently. In this sense, anesthesia might have affected the 
memory trace in animals that were re-exposed to the training context and not to non-re-exposed animals (NR) 
or non-labilized animals (R1), because the former group is the one in which the memory trace gets labile. To 
assess whether anesthesia after memory reactivation affects the behavioral output, we performed an experiment 
comparing freezing behavior in two groups of trained mice. One group was anaesthetised with isoflurane after a 
5 min re-exposure to the training context (R5-isoflurane, n = 10) and the other group was not anaesthetised after 
re-exposure (R5-control, n = 9; Fig. 2E left). Freezing was calculated both in re-exposure (24 h after training) 
and testing day (24 h after re-exposure). No differences were observed neither in the re-exposure day nor in the 
testing day (Fig. 2E right; repeated-measures GLM: day effect: F(1,17) = 18.01, P = 0.0005; drug effect: F(1,17) = 0.18, 
P = 0.684; interaction: F(1,17) = 0.07, P = 0.80; contrasts (Sidak): day 2 R5-control vs. R5-isoflurane: F(1,17) = 0.11, 
P > 0.99; day 3 R5-control vs. R5-isoflurane: F(1,17) = 0.18, P > 0,99).
Altogether, 5-min re-exposed mice exhibited differences in local brain glucose consumption compared to NR 
mice at various time-points, thus tracing a temporal course of the effects elicited by the stimuli. Within this study, 
Figure 2. Dynamics of glucose consumption in animals that express and labilizate/reconsolidate memory. (A) 
Contextual fear conditioning design. We trained three groups of mice. The next day, we re-exposed two of them 
to the training context for 5 min and injected with [18F]-FDG, either pre re-exposure or 35 min after its offset 
(R5-pre and R5-35min, respectively). The third group was not re-exposed (NR) but received FDG injection 24 h 
after training and served for comparisons. Time interval between [18F]-FDG administration and anesthesia 
was maintained at 20 min (for simplicity, both anaesthesia and acquisition of images with PET are altogether 
indicated as “PET scan”). n = 12. TR: training; Re-exp: context re-exposure. Experimental procedures in day 2 
are shown in grey. (B) Percentage of freezing on re-exposure day. Data are shown as mean ± SEM. (C) Small-
animal PET images corresponding to different coronal sections. The distance of each coronal section (in mm) 
relative to bregma is indicated in the upper scheme of the mouse brain (negative values for sections posterior 
to bregma). Data were analyzed using SPM ANOVA design and normalized through ANCOVA regressors. 
Comparisons yielding P values < 0.01 are shown using a t statistic color scale, which corresponds to the level 
of significance at the voxel level (detailed color scales in Supplementary Fig. 2). Images are displayed with the 
left side corresponding to the left hemisphere, according to neurological conventions. (D) Schematic temporal 
course of glucose consumption after 5 min re-exposure to the training context, summarizing results shown in 
Figs. 1 and 2 (Cx: cortex). (E) Anaesthesia (isoflurane) after retrieval does not affect long-term fear memory. 
Left panel: Contextual fear conditioning design. We trained two groups of mice. The next day, we re-exposed 
mice to the training context for 5 min and exposed one group to isoflurane as previously done in experiments 
in Figs. 1A and 2A, while the other group remained as control. Both groups were tested for long-term memory 
24 h after re-exposure to the training context. Right panel: Percentage of freezing on re-exposure and testing 
days. Data are shown as mean ± SEM. n = 9–10. TR: training; Re-exp: context re-exposure.
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the lateral neocortex, amygdala and hippocampus each exhibited differential glucose consumption at one or more 
of the time-points measured (Fig. 2D).
the lateral neocortex is necessary for fear memory reconsolidation. Our PET studies identified 
brain areas that were not previously implicated in contextual fear labilization/reconsolidation processes (encom-
passed here as the lateral neocortex). Therefore, we further examined the role of these areas using a functional 
study. We used a DREADD-based strategy24 to control neurons in the lateral neocortex in vivo, given that the 
designer drug clozapine N-Oxide (CNO) can be administered IP35 and not in a specific brain area, which would 
obscure PET results due to possible glucose consumption related to cannula implantation. This technique would 
allow the measurement of both behavioral output and glucose consumption using the same methodologies, with 
the advantage of neuron manipulation in specific brain areas and time windows. The chosen viral vector expresses 
both hM4D, which is an engineered version of the M4 inhibitory muscarinic acetylcholine receptor that lacks an 
endogenous ligand but is sensitive to the drug CNO36, and the fluorescent protein mCherry under the control 
of the CamkIIa promoter in the intended injection sites. We hypothesized that CNO administration near the 
reconsolidation time window would impair long-term memory if the lateral neocortex was important for the 
occurrence of that memory process.
Electrophysiological validation of DREADDs. We first injected mice in the lateral neocortex with viral vectors 
carrying hM4D (CamkIIa-hM4D-mCherry) or the control construction (CamkIIa-mCherry). Fluorescence 
indicative of mCherry expression was examined 2 weeks later to confirm viral expression (Figs. 3A,B). We also 
performed electrophysiological recordings in acute slices to examine the functionality of the expressed recep-
tor hM4D. Patch clamp recordings on fluorescent cells from CamkIIa-hM4D-mCherry injected mice indi-
cated that these cells elicited a train of action potentials upon stimulation and that puff-applied CNO silenced 
these neurons and hyperpolarized the cells afterwards (Fig. 3C). In contrast, CNO did not affect the firing fre-
quency of a non-fluorescent cell from the somatosensory cortex (Fig. 3D) or a fluorescent cell from control viral 
vector-injected animals (Fig. 3E).
PET, DREADDs and behavior. We then assessed the effect of lateral neocortex inhibition on memory reconsoli-
dation based on the results shown in Fig. 1. This experiment would also enable us to confirm the proper functional 
inhibition, which would be indicated by differential glucose consumption in target areas. Two weeks after bilateral 
injection of the CamkIIa-hM4D-mCherry viral vector, mice were trained, and CNO or vehicle solution (Veh) was 
injected IP one day after training. One hour later, mice were injected with [18F]-FDG and placed in the training 
context 10 min later for 5 min (R5-CNO and R5-Veh groups). Mice were anesthetized 5 min after removal from 
the conditioning chamber, and PET images were acquired. We assessed memory 24 h after re-exposure (i.e., 48 h 
after training; Figs. 3F,G). The R5-CNO and R5-Veh groups did not differ in glucose consumption in the targeted 
brain area (Fig. 3H; presence of color indicates significant differences with P values less than 0.01, analyzed using 
pair-wise comparisons). Two hypotheses may explain these results: no inhibition following CNO administration 
or inhibition of viral-infected cells, which was not detectable using this imaging technique. Notably, the amygdala 
was the only brain area that exhibited differences in glucose consumption between groups. The difference was 
bilateral, albeit greater on one side. In other words, inhibition of the lateral neocortex within a temporal window 
in which mice were re-exposed to the training context revealed that the amygdala consumed more glucose in 
the experimental group than in control mice. Regarding the effects on behavior, on day 2, the R5-CNO group 
showed a froze at levels similar to those of the R5-Veh group, while on day 3 the former group exhibited memory 
deficits (Fig. 3I; repeated-measures GLM: day effect: F(1,23) = 19.71, P = 0.002; drug effect: F(1,23) = 0.11, P = 0.74; 
interaction: F(1,23) = 21.32, P = 0.001; contrasts (Sidak): day 2 R5-CNO vs. R5-Veh: F(1,23) = 4.89, P = 0.073; day 
3 R5-CNO vs. R5-Veh: F(1,23) = 7.68, P = 0.022). The substantial rise in amygdalar glucose consumption and the 
CNO-elicited long-term memory deficit support the second hypothesis. This experiment also demonstrated that 
hM4D expression itself did not account for the behavioral output observed.
We performed a DREADD-based experiment including non-re-exposed (NR) animals as a control group to 
confirm whether the inhibition of the cortex of interest specifically affected the memory reconsolidation process. 
The CamKIIa-hM4D-mCherry viral vector or the control vector, CamKIIa-mCherry, was injected to examine 
the effect of the type of virus injected instead of the drug administered (Figs. 3J,K,M). Behavioral conditioning 
was performed 2 weeks after surgery. We trained all mice in the fear-conditioning paradigm, and mice injected 
with the control vector were separated into two groups the next day. One group was re-exposed to the train-
ing context for 5 min (R5-Control), and the other group was non-re-exposed (NR-Control). Mice injected with 
the hM4D vector were divided in a similar manner (R5-hM4D and NR-hM4D). All re-exposed mice received 
CNO IP 70 min prior to re-exposure to the training context (the same moment as in the experiment in Fig. 3G). 
Non-re-exposed animals were injected with CNO 24 h after training. Memory was assessed 24 h after re-exposure 
(for NR animals, 48 h after training). Both re-exposed groups froze at similar levels on day 2 (Fig. 3L; GLM, 
F(1,21) = 3.81, P = 0.064). However, re-exposed mice expressing hM4D in the cortex of interest exhibited lower 
levels of freezing than re-exposed mice expressing the control construct on day 3. These mice also exhibited 
lower levels of freezing than non-re-exposed mice expressing hM4D in the lateral neocortex (GLM: re-exposure 
effect: F(1,41) = 9.86, P = 0.003; type of virus effect: F(1,41) = 11.54, P = 0.001; interaction: F(1,41) = 14.59, P = 0.0004; 
contrasts (Sidak): R5-Control vs. R5-hM4D: F(1,41) = 26.72, P < 0.0001; R5-hM4D vs. NR-hM4D: F(1,41) = 24.85, 
P < 0.0001; NR-hM4D vs. NR-Control: F(1,41) = 0.09, P = 0.99). These latter experiment demonstrates that CNO 
itself is not an amnesic agent, which is a plausible hypothesis based on the results in Fig. 3I. Therefore, the injec-
tion of CNO together with expression of the hM4D receptor sufficiently explain the results.
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Amygdala receives monosynaptic connections from the lateral neocortex. Our results provided 
evidence of a functional connection between the lateral neocortex and the amygdala in PET analysis, which 
revealed that inhibition of the lateral neocortex altered glucose consumption levels in the amygdala (Fig. 3H). 
Therefore, we investigated the synaptic connections supporting these results. We used an optogenetic-based strat-
egy in which we expressed the light-activated cation channel rhodopsin (ChR2)37,38 in the lateral neocortex on the 
left side of the brain and implanted an electrode array plus optic fiber in the amygdala in this hemisphere. If these 
Figure 3. The lateral neocortex is necessary for contextual fear memory reconsolidation. (A) Schematic coronal 
view of a mouse brain at −2.1 mm posterior to bregma, indicating with circles the sites for patch clamp of cells 
shown in (C–E). The square indicate site for the image shown in B. (B) Morphologic validation of construct 
expression. Left: fluorescence microscopy image of CamkIIa-hM4D-mCherry expressing mouse showing 
extension of viral infection. Scale bar: 1 mm. Hip: hippocampus; CPu: caudate-putamen; In grey: lateral 
ventricle. Right: scale bar: 0.2 mm. (C) Representative Whole Cell Current Clamp recording of a fluorescent 
cell from a mouse injected in the lateral neocortex with the viral vector expressing CamkIIa-hM4D-mCherry. 
(D) Idem (C) but for a non-fluorescent cell of the primary somatosensory cortex. (E) Idem C but from a 
mouse injected with control virus CamkIIa-mCherry. CNO local puff (100 µM). +dc: depolarizing current. 
(F) Schematic coronal view of a mouse brain at −2.1 mm posterior to bregma, indicating sites of bilateral 
injection of the viral vector expressing CamkIIa-hm4D-mCherry in the lateral neocortex. (G) Contextual 
fear conditioning design. Mice expressing h m4D-mCherry in the lateral neocortex were trained and the 
next day were re-exposed for 5 min to the training context. Previous to re-exposure, some mice were injected 
with CNO IP while others were injected with vehicle solution (Veh). All mice received [18F]-FDG IP 10 min 
pre re-exposure (time point as in Fig. 1D). After re-exposure mice were anesthetized and PET images were 
acquired (for simplicity, both anaesthesia and acquisition of images with PET are altogether indicated as “PET 
scan”). Contextual fear memory was tested on day 3. n = 12–13. (H) Small-animal PET images corresponding 
to coronal sections where glucose consumption statistical differences were found. The distance of each 
coronal section (in mm) relative to bregma is indicated in the left scheme of the mouse brain (negative values 
for sections posterior to bregma). Data were analyzed using SPM ANOVA design and normalized through 
ANCOVA regressors. Comparisons yielding P values < 0.01 are shown using a t statistic color scale, which 
corresponds to the level of significance at the voxel level. Images are displayed with the left side corresponding 
to the left hemisphere, according to neurological conventions. (I) Percentage of freezing on re-exposure day 
(day 2) and testing day (day 3). Data are shown as mean ± SEM. *P < 0.05. (J) Similar as in (F), except that 
mice were either injected with viral vectors expressing hM4D-mCherry or mCherry alone (control). (K) 
Contextual fear conditioning design. All mice were trained, and half of the mice expressing hM4D-mCherry 
were re-exposed for 5 min to the training context (R5-hM4D) while the other half was not (NR-hM4D). The 
same was done for Control mice (R5-Control and NR-Control groups). Contextual fear memory was tested on 
day 3. n = 10–12. Percentage of freezing on re-exposure day (day 2) and testing day (day 3). Data are shown as 
mean ± SEM. *P < 0.05. (M) Schematic representation illustrating viral injection sites; opacity correlates with 
number of mice expressing CamkIIa-hM4D-mCherry or CamkIIa-mCherry in a given location.
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regions were connected, then light stimulation into the amygdala would excite ChR2-expressing axons reaching 
from the lateral neocortex, and a significant change in amygdalar local field potential (LFP) responses would be 
measured (Figs. 4A–F). Light-evoked responses were observed on 54% of the electrodes in the 4 mice tested, with 
a maximum peak mean latency of 6.3 msec (peri-event raster plots of two electrodes with light-evoked responses 
are shown in Fig. 4B). We further performed paired-pulse stimulation to vary the interval between light pulses 
and observed a deflection of the second pulse amplitude when the pulse delay was diminished (Figs. 4C,D), 
indicating monosynaptic connectivity between the lateral neocortex and amygdala. No light-evoked responses 
were observed in control mice that did not express ChR2 (Figs. 4G,H), which excludes the possibility of a light 
artifact. The monosynaptic connection was also assessed morphologically. The retrograde tracer cholera toxin 
subunit B (CTB) conjugated to the fluorophore Alexa Fluor 594 (AF594-CTB) was injected into the amygdala, 
and fluorescent cells were observed in the TeA, PER and other areas known to project to the amygdala such as the 
paraventricular thalamic nucleus39–41 (PV; Fig. 4I).
Discussion
In the present study we used a new approach to investigate whole-brain memory dynamics using small-animal 
PET scanning to examine the labilization and reconsolidation phases of memory. This approach revealed that 
some brain areas consumed glucose differently in animals that underwent labilization and reconsolidation. A 
broad brain zone comprising TeA, AUD and PER, termed here lateral neocortex, were part of those areas and 
its in-deep study became relevant as the knowledge of their roles in the reactivation of fear memory processes 
is scarce. A DREADD-based strategy revealed the lateral neocortex is necessary for fear memory reconsolida-
tion. Morphological and functional evidence of projections from the lateral neocortex to the amygdala was also 
demonstrated, supporting previous results obtained in rats42–44 and posing these circuits as a hot-spot involved in 
reactivation of fear memories.
It is generally believed that labilization and reconsolidation occur when memory is expressed. However, 
pharmacological studies support the independence of these processes. For instance, impairment of expression 
does not prevent labilization and reconsolidation in conditioned taste aversion45,46 or novel object recognition 
in rodents47,48, and in the context-signal memory model in the crab Neohelice granulata49. Similar results were 
observed for memory extinction50. In our experiments we included a group that only expressed the memory 
(R1) to distinguish labilization/reconsolidation from memory expression and observed differences in local 
Figure 4. Monosynaptic connection between the lateral neocortex and the amygdala. (A) Experimental design 
for items B-F. We injected ChR2 expressing viral vector in the lateral neocortex and implanted optic fiber plus 
movable-15 electrode array in amygdala. (B) Local field potential responses to 10 msec light pulses (480 nm) 
in ChR2 expressing mice (n = 4). Two electrode with responses are shown. Each of them shows a raster plot 
(above) and a histogram (below) (1 msec bins). (C,D) Paired pulse depression is observed when decreasing pre 
pulse interval, supporting a pre-synaptic effect. (E) Placement of the tip of the cannulae containing the movable 
electrodes (Scale bar: 2 mm). (F) Fluorescence microscopy images showing ChR2-YFP expression. Scale 
bars: 2 mm. Note that no somatic expression is seen in amygdala. (G) Same as in (A) except that mice did not 
expressed ChR2 -control- (n = 2). (H) Same as in (B) but using control mice. (I) Alexa Fluor 594 CTB (AF594-
CTB) injection in amygdala (upper; Scale bar 1 mm) rendered red-somas in the lateral neocortex (lower; scale 
bar 30 µm), particularly in the TeA, PER, and paraventricular thalamic nucleus (PV).
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brain glucose consumption between the R1 group and the group that also underwent labilization and recon-
solidation (R5), which supports the hypothesis that the areas that exhibited significant differences were differ-
entially involved in labilization/reconsolidation processes. However, the R5 group also expressed the memory 
for longer time periods, which makes it impossible to completely exclude an effect of a longer expression. The 
DREADD-based experiments allowed us to assess this potential effect: levels of freezing during re-exposure were 
similar in control and experimental groups despite being under the expected effect of CNO35, which strongly 
suggest that the effects observed in the present work were due to labilization/reconsolidation processes.
Brain sites involved in contextual fear memory reconsolidation. Different parts of the brain are rel-
evant for the reconsolidation of particular types of memory depending on the learning paradigm. The hippocam-
pus and the amygdala are the most-studied brain areas for contextual fear memories because of their importance 
in encoding contextual information and emotions, respectively51. Other cortical brain areas are also necessary 
for contextual memory reconsolidation, primarily the pre-limbic subregion of the medial prefrontal cortex 
(PL-mPFC)52–54, the anterior cingulate cortex (ACC)55,56, and the entorhinal cortex51,57. In our experiments, we 
affected reconsolidation of a contextual fear memory through chemogenetic inhibition of a brain area comprising 
mainly the TeA and AUD, with the PER in a lesser extent (Fig. 3). Information about the role of these three areas 
in fear reconsolidation, especially in contextual-based conditionings, is scarce. In regard to the TeA, it has been 
shown that it (together with AUD according to histology) is necessary for remote cued memory recall, and that 
different genes are expressed after cued fear conditioning58. Concerning the PER, previous studies assessed its 
role in reconsolidation of both cued and contextual fear memories. Regarding contextual fear memories, lesions 
in PER at different time-points after training affects memory expression59; CA1 engram cells inhibition affects 
expression and diminishes PER activation60. Another study performed in cued fear conditioning found that TTX 
inactivation of PER after recall did not affect reconsolidation61. These latter results, albeit performed using cued- 
shock associations, contradict our findings. However, the differences might be attributed to the timing of drug 
administration. With respect to AUD role in reconsolidation of fear memory, using a cued based paradigm it has 
been shown that AUD is activated after retrieval62,63 and AUD lesion affects memory expression64. Considering 
our results showing AUD relevance in contextual fear reconsolidation, further investigations are needed to fully 
understand its possible integrative role in this type of memory trace. It is worth to note that AUD refers to several 
areas, such as the primary auditory cortex, the ventral and dorsal secondary auditory cortex, which differ in affer-
ents and efferents and have different roles in processing and integration of information42. Our PET results and 
DREADDs expression cannot distinguish between them but for sure includes secondary ventral auditory cortex.
In fact, a limitation of our study is the resolution of the PET methodology. The areas PER, TeA and AUD are 
physically very close to each other, so it is still not known whether the three of these areas, some of them or even 
smaller regions of each are necessary for contextual fear reconsolidation. Therefore, this technique could be well 
complemented with others with cellular resolution, such as immediate-early genes (IEGs) activation mapping. 
Combining both approaches would enable a deeper understanding of the neuronal processes, as PET provides 
the advantage of studying activation patterns in an intact, living brain and IEGs mapping allows to improve their 
resolution in fixed tissue. It is worth to note that the PET experiments were performed to evaluate cumulative 
glucose consumption within a brief period of time (from [18F]-FDG administration to image acquisition) at dif-
ferent times after the beginning of the re-exposure session (see Results section). Therefore, other brain areas with 
known involvement in the process (see above) may have been overlooked in this study.
Previous work used small-animal [18F]-FDG-PET scanning to examine areas that are differentially involved 
in expression of contextual and cued conditioning22. The authors analyzed glucose consumption during fear 
memory testing on three groups of rats: One that had been trained using a pairing of tones and shocks (“FEAR” 
group), other which had been trained using tone and shocks in an unpaired scheme (“ANX” group), and a third 
control group (“CTRL”) which had only been exposed to the tones in the training context. The authors compared 
the ANX and CTRL groups and the ANX and FEAR groups respectively and observed a hyper-metabolism in 
brain areas that comprised the bed nucleus of the stria terminalis (BST) in the ANX group in both comparisons, 
which provided new evidence for a role of the BST in the expression of contextual memory. The ANX group 
is similar to our R5 group in the elicitation of contextual fear memory expression. However, it is worth noting 
that their testing parameters may also have elicited labilization/reconsolidation processes. The use of un-shocked 
(CTRL) animals as a control for comparisons makes it difficult to determine whether ANX-induced differential 
consumption after testing was due to consolidation-related processes, expression, or labilization/reconsolidation. 
The inclusion of a non-re-exposed trained group (termed NR) in our experiments excludes the possibility of 
consolidation-related mechanisms as an explanation of our results.
Glucose consumption, PET and memory processes. Regarding glucose consumption, it is interesting 
to analyze its underlying biological meaning as PET provides a 3D map of [18F]-FDG local consumption but 
does not identify the cellular components of the local areas that are metabolically active. Despite the growing 
knowledge about glia importance in brain metabolic processes65 and cognition66,67, together with the increasing 
use of [18F]-FDG in PET for both clinical studies and basic research, it still remains controversial which cell types 
contribute to the [18F]-FDG PET signal68,69. Zimmer et al. recently reported direct evidence that activation of 
astrocytic glutamate transport via the excitatory amino acid transporter GLT-1 triggered a widespread but graded 
glucose uptake in the rodent brain using PET and claimed that astrocytes should be recognized as contributing 
to the [18F]-FDG signal70.
New learning, along with the further processing of information, initiates a cascade of cellular events that 
require high metabolic demands (e.g., gene expression, protein synthesis, and neuronal firing). Therefore, our 
initial hypothesis was that mice that underwent memory reprocessing after retrieval (i.e., reconsolidation) 
would exhibit greater glucose consumption than mice that did not. However, PET results revealed not only 
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hyper-consumption but also hypo-consumption of glucose. Notably, the hypo-consumption appeared in brain 
regions known to be involved in the reconsolidation phase of memory, such as the hippocampus and amygdala, 
according to different studies that investigated the need of energy-demanding processes, such as gene transcrip-
tion and protein synthesis71–73. However, hypo-signals are not unusual in healthy brain studies. Luyten et al. 
performed small-animal [18F]-FDG-PET studies and found hypo-consumption in areas critical for emotional 
behavior, including the amygdala22. The simultaneous consideration of all of the different players in the brain 
(excitatory/inhibitory neurons and glia) acting in concert during animal behavior is important to further eluci-
date hyper- and hypo-consumption. The PET final glucose consumption signal is related to the balance of these 
metabolically active cells.
Looking forward. Cognitive function is conceived as a product of the concerted and synchronized activity of 
many brain areas in a hierarchical relation, with a low number of highly connected brain regions or nodes (hubs) 
and a high number of lower connected nodes74,75. Despite this network comprehensive concept of the brain, few 
studies have used brain-wide techniques to understand brain function in small animals and most of them have 
relied on fixed tissue to do so76–80 but see81. Here, we provide new insights in the study of the dynamics of the acti-
vation of brain areas during the reprocessing of the mnemonic trace due to behavioral experience using a novel 
technique for the field, small-animal PET. Understanding the processes elicited by memory retrieval is impor-
tant for its theoretical value and provides insight into pathologies related to memory dysfunctions to aid in the 
development of therapeutic strategies14,16,17. Brain wide-techniques provide new information on areas involved 
in cognitive processes in a dynamic manner and help tackle the challenge of investigating cognitive functions by 
simultaneously considering the coordinated activity of multiple brain regions.
Materials and Methods
Animals. Male C57BL/6 mice 8–12 weeks old, weighting 25–30 g (La Plata University animal facilities, La 
Plata, Argentina; NIH, USA) were housed in groups of 4–5 except for cannulated/implanted mice, which were 
individually housed. In all cases, they were provided with water and food ad libitum under a 12 h light/dark 
cycle (lights on at 8:00 A.M.) at a temperature of 21–23 °C. Experiments were performed during the light cycle 
(between 9 A.M. and 4 P.M.) and were designed and performed with the approval of the University of Buenos 
Aires Institutional Animal Care and Use Committee (CICUAL N°29/2014) and in accordance with regulations 
of the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH publication 
80–23/96), USA. We made all efforts to minimize animal suffering and to reduce the number of animals used.
Behavioral procedures. Before training, the animals were handled once a day for two days. The training 
session consisted of placing each mouse in the conditioning chamber and allowing two min adaptation period 
after which it received three foot-shocks (0.6 mA, 1 s) separated by an interval of 1 min. After the final foot-shock, 
the mouse remained in the chamber for an additional min and returned to its home cage. One day after training 
the mice were re-exposed to the training context without presenting foot-shocks for either 5 or 1 min, or were 
no re-exposed at all. Further contextual test was performed 48 h after training by placing the mice in the train-
ing environment for 5 min in the absence of the foot-shock. Each session was videotaped to calculate freezing, 
defined as the absence of all movements except those related to breathing, and scored blindly according to an 
instantaneous time-sampling procedure in which each animal was observed every 5 s in the whole length of 
each session. Memory was assessed and expressed as the percentage of time that mice spent freezing, which is 
commonly used as an index of fear in rodents82. In specified experiments, PET analysis was performed in the 
re-exposure day. For details on the conditioning chamber see83.
We consider memory expression when the experimenters detect what has been specified as the operative 
measure of memory (in this case, freezing), that is, memory expression refers to behaviour. We consider memory 
labilization as the circuital changes that makes the trace labile, and is elicited under the presentation of certain 
types of reminders. Reconsolidation, in turn, is the process that re-stabilizes that trace. In PET studies we will not 
be able to differentiate between both processes, and thus the changes seen will be attributable to both. However, in 
pharmacological experiments in which the operative measure of memory is lower than in controls, we will assign 
the effect to a reconsolidation disruption (e.g. with anisomycin or with chemogenetic-mediated inhibition of neu-
rons). When labilization is disrupted, on the contrary, the effect would be to see no changes in freezing (memory 
does not became labile, and thus cannot be disrupted). The term reactivation will be used to refer to the circuital 
process that allow labilization/reconsolidation, and not to the circuit process subserving memory expression.
cannulae implantations. For ICV injections, mice were deeply anesthetized (100 mg ketamine and 10 mg 
xylazine per kg. body weight co-injected IP) and placed in a stereotaxic frame. After exposing the skull, one 23 
gauge guide cannula was implanted dorsally to either the left or right ventricle at coordinates: −0.2 mm anter-
oposterior from bregma; 1 mm lateral from midline; −1.2 mm ventral from skull surface; in accordance with 
the atlas of Franklin and Paxinos84 and personal adjustments. Guide cannulae were fixed to the skull with dental 
acrylic containing calcium hydroxide. While anesthetized, mice received one dose of antibiotic (enrofloxacin, 
85 mg/kg) co-injected with analgesic SC (meloxicam, 5 mg/kg), and after surgeries were administered PO with 
analgesic (tramadol, 20 mg/ml, in the water bottle). Experiments were performed following animal recovery and 
drug injections were administered without anaesthesia. The injection device consisted of a 30 gauge cannula 
connected to a 5 µl Hamilton syringe by tubing. Initially, the injection device was filled with distilled water and a 
small air bubble was sucked into the injection cannula, followed by the injection solution. The air bubble allowed 
for visual inspection of the injection progress. The injection cannula was inserted into the guide cannula with 
its tip extending beyond the guide by 1 mm in order to reach the aimed zone. The injections were administered 
during 30 s and operated by hand. The injection cannula was removed after 60 s in order to avoid reflux and to 
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allow the diffusion of drugs. The volume of each injection was 1 µl. Different injection devices were used for drug 
and vehicle. To verify cannulae placement, after behavioral procedures the animals were killed and their brains 
were placed in 4% paraformaldehyde (PFA) for one day followed by 30% sucrose in PBS for an additional 24 h. 
Brains were sliced using a vibratome and analyzed with a magnifying glass. Only data from animals with cannulae 
located in the intended sites were included in the analysis.
Chemogenetics. For viral injections, we anesthetized the mice as mentioned before and bilaterally 
injected an anterograde adeno-associated viral vector (AAV5) carrying a cre-recombinase independent 
hM4D fused to mCherry, under the control of the excitatory neuronal promotor CamkII or control vector 
(AAV5-CamkIIa-hM4D-mCherry and AAV5-CamkIIa-mCherry, respectively; ~0.25 µl/side; University of North 
Carolina Vector Core) into the lateral neocortex, using microcapillary calibrated pipettes and a Picospritzer II 
(Parker Hannifin Corp). Coordinates were: 2.1 mm anteroposterior from bregma; ±4.5 mm lateral from midline; 
1.3 mm ventral from brain surface (2° angled towards the left, in the left injection and 2° towards the right, in the 
right injection) in accordance with the atlas of Franklin and Paxinos84 and personal adjustments. Behavioral and 
PET acquisition were performed two weeks after viral injections. Mice received a single IP CNO injection (see 
Results). After experiments finished, mice were terminally anesthetized with ketamine/xylazine and transcardi-
ally perfused first with saline and then with 4% PFA. Brains were post-fixed in PFA ON and remained in PBS until 
used. Coronal sections were prepared for fluorescence analysis to check viral expression in the intended sites.
Drugs. Anisomycin (Sigma, A9789) was first dissolved in acidic saline, then taken to pH ~7.5; and was 
injected ICV at 0.1 mg/µl. CNO (NIH) was administered IP at 5 µg/g35. It was first dissolved in DMSO, then in 
saline (final DMSO 2.5%). Timing of CNO administration was based on previous literature in order to achieve 
the greatest neuronal inhibition35 during the expression of memory.
Whole-cell patch-clamp recordings in vitro using brain coronal slices. Mice were deeply 
anesthetized with tribromoethanol (250 mg/kg; IP) followed by transcardial perfusion with ice-cold 
N-methyl-D-glucamine based artificial cerebrospinal fluid (NMDG-aCSF) (composition in mM: 92 NMDG, 
2.5 KCl, 1.25 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 2 thiourea, 5 Na-ascorbate, 3 Na-pyruvate, 0.5 
CaCl2· and 10 MgCl2. pH was adjusted to 7.3–7.4 with concentrated hydrochloric acid, and aerated with 95% 
O2/5% CO2), and then decapitated. Coronal brain slices (300 μm) were obtained gluing both hemispheres onto 
a vibratome aluminum stage (Integraslicer 7550 PSDS, Campden Instruments, UK), submerged in a chamber 
containing NMDG-aCSF. Slices were sequentially cut and transferred to an incubation chamber containing 
NMDG-aCSF at 35 °C for 30 min and then transferred to a second chamber containing low Ca2+/high Mg2+ 
normal aCSF (composition in mM: 125 NaCl, 2.5 KCl, 3 MgSO4, 0.1 CaCl2, 1.25 NaH2PO4, 0.4 ascorbic acid, 3 
myo-inositol, 2 pyruvic acid, 25 d-glucose, and 25 NaHCO3 and aerated with 95% O2/5% CO2, pH 7.4) for 30 min 
prior whole-cell recordings.
Differential interference contrast optics was used to visualize neurons using an upright Nikon PERlipse micro-
scope (Nikon, Germany) coupled to a 530 nm high power LED collimator source (Mightex Systems, Canada). 
Whole-cell patch clamp recordings were made at 30 °C in aCSF containing normal MgCl2 (1 mM) and CaCl2 
(2 mM). Patch electrodes were made from borosilicate glass (2–3 M∧) filled with a current-clamp high K+ intra-
cellular solution (composition in mM: 110 K+-Gluconate; 30 KCl; 10 Hepes; 10 Na2phosphocreatine; 0.2 EGTA; 
2 Mg-ATP; 0.5 Li-GTP; 1 MgCl2; pH was adjusted to 7.3 with KOH). No spontaneous action potentials discharge 
was observed at the resting membrane potential. Despolarizing direct current injection (50–150 pA) was deliv-
ered in order to generate tonic action potentials. Electrical signals were recorded using an AxoClamp 200B ampli-
fier commanded by pCLAMP 10.0 software (Molecular Devices, CA, USA). Data were filtered at 5 kHz, digitized 
and stored for off-line analysis using Clampfit. CNO was prepared as a stock solution in DMSO and aliquots 
were stored at −20 °C. CNO aliquots were unfrozen fresh every day and locally delivered using a Picospritzer 
II (General Valve Corporation, Fairfield, NJ) coupled to a puff glass pipette filled with CNO (100 µM in normal 
aCSF, 1% DMSO) and located at distance of ~50 μm from the recorded mCherry expressing-patch-clamped 
cortical pyramidal neuron.
Preclinical Positron Emission Tomography imaging. Animal handling. Four h starved mice were 
IP injected with 25 µCi/g [18F]-FDG at different times prior to- or after the beginning of the re-exposure to 
the training context. Thirty min before [18F]-FDG injection and during the first stage of the radiopharmaceu-
tical incorporation, while waiting for PET acquisition, mice were left undisturbed in individual home cages in 
a 29 °C environment, to which they habituated 2 days before the experiments. In order to optimize the regional 
[18F]-FDG contrasts in relation to basal conditions, all protocols were designed so that the behavioral moment of 
interest for glucose consumption analyses occurred in concordance with the maximum radiotracer availability on 
plasma, which was reported to be 10 min after [18F]-FDG IP injection34. For PET acquisition, mice were anesthe-
tized under a mix of isoflurane (4.5% for induction and 1.5% for maintenance) and O2 for approximately 2–3 min 
and then put in the tomograph, which maintained their body temperature at 35 °C during the acquisition. After 
acquisition, mice were returned to their home cages, and in some experiments were tested for long-term contex-
tual memory 48 h after TR.
Imaging system. Images were acquired using a preclinical PET TriFoil LabPET 4 with LYSO and GYSO crystals 
and 1536 APD detectors groups. Approximated spatial resolution FWHM = 1.2 mm (full width at half maxi-
mum), 3.7 cm axial and 11 cm trans-axial field of view (FOV).
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Acquisition and reconstruction setup. Each PET acquisition lasted 12 min -list-mode acquisition-. Images were 
reconstructed using OSEM 3D algorithm with 30 iterations, by which the best signal to noise ratio was achieved. 
If motion was detected during acquisition, dynamic reconstruction was performed in order to correct it using 
SPM5 on MATLAB® realign algorithm.
Image spatial processing. The images were confined to a bounding-box only including the brain. A normal 
subject-based template was created in order to have an anatomic reference for realignment and normalization. 
All images were smoothed using an isotropic Gaussian kernel with 1 mm FWHM. Images were co-registered 
and normalized to this template using SPM5 on MATLAB®, with the following parameters: normalized mutual 
information as objective function and 7 mm smoothing histogram for rigid co-registration; affine regularization 
to the averaged template size, no-smooth and 2–0.1 mm of separation for the non-rigid normalization. Previous 
to intensity normalization and statistical analysis, a brain masking avoiding Harderian glands was applied to all 
subjects, since the uptake in these glands can significantly modify the intensity normalization values (data not 
shown).
In vivo electrophysiology and optogenetics. Adeno-associated viral vector carrying ChR2 fused 
to GFP, under the control of the CAG promoter was unilaterally injected into the left lateral neocortex (same 
coordinates as in chemogenetics section). Recordings were made using a drivable electrode array (Innovative 
Neurophysiology Inc.) implanted unilaterally together with an optic fiber in the left amygdala. Coordinates were 
1.5 mm anteroposterior from bregma; 3.3 mm left from midline; 3.7 mm ventral from brain surface. After sur-
gery, electrodes downed further 0.5 mm, to finally reach the intended site. For optical stimulation, we applied 
blue light pulses of 10 msec, 1 Hz. In the case of paired pulse experiments, 10 msec blue light pulses were sepa-
rated with intervals of 100, 40 and 20 msec. Data was processed with commercial software (Offline Sorter and 
Neuroexplorer; Plexon). After experiments mice were deeply anesthetized and perfused first with saline and then 
with PFA 4%. Brains were post-fixed in PFA overnight and remained in PBS 30% sucrose until used. Coronal 
sections were checked for fluorescence in the lateral neocortex and the correct placement of electrodes.
Morphologic studies. We performed neuroanatomical retrograde tracing according to Conte et al.85. Briefly, 
mice were anesthetized as mentioned before and were injected with 0.12 µl of CTB conjugated with Alexa Fluor-
594 (Invitrogen, cat. no. C22842) 0.5% w/v diluted in saline, into the left amygdala. Coordinates were: 1.6 mm 
anteroposterior from bregma; 3.3 mm left from midline; 4.9 mm ventral from bregma. Seven days after injec-
tion we perfused the mice first with saline and then with PFA 4%. Brains were post-fixed in PFA overnight and 
remained in PBS 30% sucrose until used. Coronal sections were prepared for fluorescence analysis. Fluorescence 
images were taken with confocal microscope/episcope depending on the magnification, and brightness/contrast 
was modified to better visualize marked cells.
Experimental design and statistical analysis. Behavioral experiments. Numbers of mice (n) in each 
group are shown in Figure Legends. All data are shown as mean ± SEM. Freezing scores were analyzed by General 
Linear Models (GLM) and Akaike information criterion was considered in order to choose the best variance 
structure. LSD comparison test was performed to compare data between groups. To test for homocedasticity and 
normality assumptions, we considered residual dispersion graphs together with Levene and Shapiro-Wilks tests, 
respectively (InfoStat 2016. Grupo InfoStat, FCA, Universidad Nacional de Córdoba, Argentina; R Foundation 
for Statistical Computing, Vienna, Austria). When more than one behavioral test was performed to all the groups 
in one experiment, data were analyzed as repeated measures. When the experiment included more than one treat-
ment and more than one behavioral test, which was performed to some of the groups in one experiment but not 
to all (i.e. Non re-exposed animals are not evaluated in re-exposure day), we analyzed data of each day separately. 
We performed post-hoc contrasts corrected for multiple comparisons (Sidak). A significance level of P < 0.05 was 
used for all behavioral analyses.
PET Image statistical analyses. All groups of subjects were analyzed as a multi-factorial ANOVA test using SPM5 
on MATLAB®. Intensity normalization was considered as a regressor variable for each factor using grand mean 
scaling and ANCOVA. Global calculation of individual means was calculated over each masked brain. In order 
to have an accurate anatomical reference, all results of statistical differences where co-registered with an MRI 
atlas86. Spatial transformation was applied to the MRI atlas to correct for the differences between mice strains and 
methodological animal. Only brain areas showing statistical differences in glucose consumption between groups 
in two or more replicates of the experiments were considered throughout the paper.
Significant statement. The ability to learn from environmental stimuli is universal the animal kingdom 
and it enables to develop adaptive behaviors. Consequently, the ability to remember what has been learnt has a 
relevant role in every animal’s life. Besides, cognitive function is a product of the concerted and synchronized 
activity of many brain regions. However, the study of the physiology underlying memory in small animals using 
whole-brain techniques is scarce. Using Positron Emission Tomography and chemogenetics, we show that the 
lateral neocortex is necessary for fear reconsolidation, a mnemonic process that enables strengthening and updat-
ing of memory. Inhibition of lateral neocortex during reconsolidation changed glucose consumption levels in the 
amygdala, a key region for emotional memories, where the lateral neocortex projects to.
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